Literature DB >> 19082883

Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.

Meredith J Noetzel1, Marianne K O Grant, Esam E El-Fakahany.   

Abstract

Xanomeline is thought to be a M1/M4 functionally selective agonist at muscarinic receptors. We have previously demonstrated that it binds in a unique manner at the M1 receptor. In the current study, we examined the ability of xanomeline to bind to the M3 receptor and determined the long-term consequences of this mode of binding in Chinese hamster ovary cells expressing M3 receptors. Xanomeline binds in a reversible and wash-resistant manner at the M3 receptor and elicits a functional response under both conditions. Long-term exposure to xanomeline resulted in changes in the binding profile of [(3)H]NMS and a decrease in cell-surface receptor density. Additionally, pretreatment with xanomeline was associated with antagonism of the functional response to subsequent stimulation by conventional agonists. Our results indicate that xanomeline binds to and activates the M3 muscarinic receptor in a wash-resistant manner, and that this type of binding results in time-dependent receptor regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082883      PMCID: PMC3752336          DOI: 10.1007/s11064-008-9886-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

1.  Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.

Authors:  J Hu; S Z Wang; E E el-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

2.  Agonist-induced down-regulation of m1 muscarinic receptors and reduction of their mRNA level in a transfected cell line.

Authors:  S Z Wang; J R Hu; R M Long; W S Pou; C Forray; E E el-Fakahany
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

Review 3.  Model systems for the study of seven-transmembrane-segment receptors.

Authors:  H G Dohlman; J Thorner; M G Caron; R J Lefkowitz
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

Review 4.  Allosteric antagonists of the muscarinic acetylcholine receptor.

Authors:  N H Lee; E E el-Fakahany
Journal:  Biochem Pharmacol       Date:  1991-07-05       Impact factor: 5.858

5.  Down-regulation of the G-proteins Gq alpha and G11 alpha by transfected human M3 muscarinic acetylcholine receptors in Chinese hamster ovary cells is independent of receptor down-regulation.

Authors:  E van de Westerlo; J Yang; C Logsdon; J A Williams
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

6.  Agonist-induced muscarinic cholinergic receptor internalization, recycling and degradation in cultured neuronal cells. Cellular mechanisms and role in desensitization.

Authors:  J M Maloteaux; E Hermans
Journal:  Biochem Pharmacol       Date:  1994-01-13       Impact factor: 5.858

7.  Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Correlation with down-regulation of cell surface receptors.

Authors:  C L Cioffi; E E el-Fakahany
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

8.  Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.

Authors:  S Z Wang; E E el-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

9.  The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's disease.

Authors:  J J Sramek; N R Cutler; D J Hurley; R D Seifert
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

10.  Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.

Authors:  H E Shannon; F P Bymaster; D O Calligaro; B Greenwood; C H Mitch; B D Sawyer; J S Ward; D T Wong; P H Olesen; M J Sheardown; M D Swedberg; P D Suzdak; P Sauerberg
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

View more
  2 in total

Review 1.  Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.

Authors:  Chad R Johnson; Brian D Kangas; Emily M Jutkiewicz; Jack Bergman; Andrew Coop
Journal:  Biomedicines       Date:  2022-02-07

2.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.